Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 94 results for "ajanta pharma"

Ajanta Pharma posts Q4 FY 15 results

Standalone Q4 revenue has shown a growth of 19 per cent and PAT growth of 20 per cent Ajanta Pharma has posted its performance for the fourth quarter and year ended March 31, 2015. The Q4 FY 15 standalone results show that revenue from operations ... Financial Express, 2 weeks ago

4 images for ajanta pharma

India Infoline, 2 weeks ago
Money Control, 2 weeks ago
Value Research Online, 3 weeks ago
India Infoline, 3 weeks ago
Livemint.com

Lupin to replace Tata Power on BSE from 22 June

A file photo of the Bombay Stock Exchange. Photo: Hindustan Times Mumbai: Pharmaceutical firm Lupin Ltd will be included in the benchmark S&P Sensex with effect from 22 June in place of Tata Power Co. Ltd, as per a statement issued by BSE Ltd.
 Livemint.com3 days ago Tata Power to lose Sensex rank; Tata Motors DVRs in indices  Hindu Business Line5 days ago Lupin to replace Tata Power in Sensex; DVRs to make index debut  Business Standard India5 days ago Lupin to replace Tata Power in BSE Sensex  Jagran Post5 days ago
Rediff.com

Keen to invest in equities? These stocks will give you good returns

Shares of companies to be included in the India-related MSCI indices have outperformed the market, ahead of their inclusion in the index. Except Lupin, Bharat Forge and Container Corporation of India (up less than two per cent each), all the remaining five stocks to be included in the MSCI India Index — Bharti Infratel, Shree Cement, UPL, Eicher Motors and Marico — have rallied between seven per cent and 14 per cent in the past two weeks on BSE. In comparison, the BSE Sensex and ...
 Rediff.com6 hours ago 33 stocks outperform markets ahead of MSCI inclusion  Smart Investor7 hours ago 41 stocks see outperformance on MSCI inclusion  Smart Investor1 day ago

Ultratech Cement, ACC to get astro suport: Satish Gupta

To-day's Planetary Position: Moon will be transiting in Pisces. Jupiter in Cancer. Lord Rahu in Virgo, Lord Saturn in Scorpio. Sun in Aries, Mars & Mercury in Taurus, Venus in Gemini. Ketu in Pisces.Pluto in Sagittarius. Neptune in Aquarius & Uranus ...
 Moneycontrol.com1 week ago
Business Standard

Ajanta Pharma falls on profit booking

Ajanta Pharma fell 1.87% to Rs 1,385 at 13:53 IST on BSE on profit booking after gaining 11.52% in prior three trading days. Meanwhile, the S&P BSE Sensex was down 108.52 points or 0.41% at 26,608.85 On BSE, so far 36,426 shares were ...
 Capital Market3 weeks ago BRIEF: BSE announces reconstitution of Sensex [Mint, New Delhi]  Bloomberg5 days ago Stock market prediction for April 20-24: Satish Gupta  Money Control1 month ago Pharma shares dip on profit booking  Business Standard India1 month ago
[x]  
Value Research Online

Ajanta Pharma allots equity shares

This page uses frames, but your browser doesn't
 Capital Market2 weeks ago Board of Ajanta Pharma recommends final dividend  Capital Market2 weeks ago Ajanta Pharma: New Drug Gainer  Value Research Online3 weeks ago Ajanta Pharma's FY15 results on May 8, 2015  Money Control1 month ago
[x]  
India Infoline

Ajanta Pharma zooms 5% on high volume

News Top News Top Story India Infoline News Service | Mumbai | May 06, 2015 16:04 IST NSE announced that the stock along with six others will be included in its futures and options (F&O) segment from 29 May, 2015. Article saved successfully ...
 India Infoline3 weeks ago Ajanta Pharma stock surges 7% on high volume  India Infoline3 weeks ago

Ajanta Pharma net up 20 percent in Q4

Drug major Ajanta Pharma Ltd has posted Rs.84 crore net profit for fourth quarter of 2014-15, registering 20 percent year-on-year (YoY) on standalone basis.In a regulatory filing to the stock exchanges on Friday, the city-based specialty focused ...
 Prokerala2 weeks ago Ajanta Pharma net surges by 20% in Q4, dividend at 300% for 2014-15  PharmaBiz2 weeks ago Performances of top 25 Indian pharma cos in 9 months indicate 2014-15 a tough year  PharmaBiz1 month ago HUL net up 17 percent in Q4  NewsR.in2 weeks ago
[x]  
India Infoline

Ajanta Pharma Q4 net up 20% at Rs 84.31 cr

Ajanta Pharma reported a 20 per cent rise in standalone net profit to Rs 84.31 crore for the quarter ended March 31, 2015 on robust sales. The company had posted net profit of Rs 70.09 crore for the January-March period of the previous fiscal, ...
 Hindu Business Line2 weeks ago Ajanta Pharma Q4 Net Profit at Rs.84.3 Crore  India Infoline2 weeks ago Ajanta Pharma leads the gainers of group A on BSE  Finalaya.com3 weeks ago Ajanta Pharma Q4 net profit up 20% at Rs 84.31 crore  Economic Times2 weeks ago
[x]  
India Infoline

Ajanta Pharma stock ends 8% lower

The company had fixed 23 March, 2015, as the record date for the proposed stock split, wherein each share with a face value of Rs. 5 will be sub-divided to a face value of Rs. 2 each. Shares of Ajanta Pharma rallied over 2 per cent to touch a high of Rs.
 India Infoline2 months ago Ajanta Pharma gains on turning ex-split  India Infoline2 months ago Ajanta Pharma turns ex-split on Friday  Hindu Business Line2 months ago Ajanta Pharma closed 8% higher on BSE  India Infoline2 months ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ajanta pharma
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less